ZYXI: Zynex Inc Company Profile & Statistics

About

Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.

Info & Links

CEO

Thomas Sandgaard,

Headquarters

9655 MAROON CIRCLE
ENGLEWOOD, CO 80112, UNITED STATES

Auditor

Marcum LLP

Share holders

188

Employees

1,100

Zynex Inc Statistics

Valuation Measures

Market Capitalization²

271.36M

Enterprise Value

293.26M

Enterprise Value/EBITDA(ttm)

21.92

Price to Earnings Ratio(ttm)

54.27

Price to Sales(ttm)

1.34

Price to Book(mrq)

7.25

Price to Cash(ytd)

19.78

Profitability

Gross Margin(ttm)

79.48%

Operating Margin(ttm)

2.49%

Profit Margin(ttm)

2.45%

Return on Equity(ttm)

13.05%

Return on Invested Capital(ttm)

5.01%

Return on Assets(ttm)

3.78%

Income Statement

Revenue(ttm)

193.66M

Revenue Per Share(ttm)

6.08

Gross Profit(ttm)

153.95M

EBITDA(ttm)³

13.38M

Net Income Available to Common(ttm)

4.82M

Diluted EPS(ttm)

0.15

Share Statistics

Beta (5Y Monthly)

0.49

52-Week Change

2.28%

S&P 500 52-Week Change

27.86%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

31.85M

Dividend Yield

0.00%

Float⁴

15.24M

% Held by Insiders

52.13%

% Held by Institutions

29.68%

Balance Sheet

Total Cash(mrq)

37.63M

Total Cash Per Share(mrq)

1.18

Total Debt(mrq)

59.53M

Total Debt/Equity(mrq)

166.40%

Current Ratio(mrq)

3.94%

Quick Ratio(mrq)

3.15%

Book Value Per Share(mrq)

1.12

Cash Flow

Operating Cash Flow Per Share(ytd)

0.32

Free Cash Flow(ytd)

9.91M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ZYXI

Zynex Inc

Zynex Inc Profile